Published in
Taylor and Francis Group, OncoImmunology, 1(8), 2018
DOI: 10.1080/2162402x.2018.1512329
Links
Tools
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials
Journal article published in 2018 by
Jonathan G. Pol 
,
Sergio A. Acuna ,
Beta Yadollahi,
Nan Tang,
Kyle B. Stephenson,
Matthew J. Atherton,
David Hanwell,
Alexander El-Warrak,
Alyssa Goldstein,
Badru Moloo,
Patricia V. Turner,
Roberto Lopez,
Sandra LaFrance,
Carole Evelegh,
Galina Denisova
and other authors.
,
Sergio A. Acuna ,
Beta Yadollahi,
Nan Tang,
Kyle B. Stephenson,
Matthew J. Atherton,
David Hanwell,
Alexander El-Warrak,
Alyssa Goldstein,
Badru Moloo,
Patricia V. Turner,
Roberto Lopez,
Sandra LaFrance,
Carole Evelegh,
Galina Denisova
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 